gms | German Medical Science

62. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e. V. (GMDS)

Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie

17.09. - 21.09.2017, Oldenburg

Comparing treatments evaluated in studies which form disconnected networks of evidence: A review of methods

Meeting Abstract

Search Medline for

  • John Stevens - Centre for Bayesian Statistics in Health Economics, University of Sheffield, Sheffield, Vereinigtes Königreich Großbritannien und Nordirland

Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie. 62. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e.V. (GMDS). Oldenburg, 17.-21.09.2017. Düsseldorf: German Medical Science GMS Publishing House; 2017. DocAbstr. 178

doi: 10.3205/17gmds039, urn:nbn:de:0183-17gmds0399

Published: August 29, 2017

© 2017 Stevens.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

A network meta-analysis allows a simultaneous comparison between treatments evaluated in RCTs that share at least one treatment with at least one other study. Estimates of treatment effects may be required for treatments across disconnected networks of evidence, which requires a different statistical approach and modelling assumptions to account for imbalances in prognostic factors between studies. In this paper, we review and discuss methods for comparing treatments evaluated in studies which form disconnected networks of evidence. Several methods have been proposed [1], [2], [3], [4], [5], [6], [7], [8], [9], [10] but assessing which are appropriate often depends on the clinical context as well as the availability of data. Most methods account only for sampling variation. We suggest that further research is required to assess the properties of methods and the use of approaches that allow the incorporation of external information to reflect parameter and structural uncertainty.

Der Vortrag gehört zum Workshop "Methods for Generalized Evidence Synthesis".

Organisatoren: R. Bender, K.H. Herrmann, K. Jensen, D. Hauschke, F. Leverkus & T. Friede

Die Autoren geben an, dass kein Interessenkonflikt besteht.

Die Autoren haben keine Angabe zur Beratung durch einen Ethikkommission gemacht.


References

1.
Austin PC, Stuart EA. The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes. Stat Methods Med Res. 2015 Apr 30. pii: 0962280215584401. DOI: 10.1177/0962280215584401 External link
2.
Caro JJ, Ishak KJ. No head-to-head trial? simulate the missing arms. Pharmacoeconomics. 2010;28(10):957-67. DOI: 10.2165/11537420-000000000-00000 External link
3.
Dequen P, Lorigan P, Jansen JP, van Baardewijk M, Ouwens MJ, Kotapati S. Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma. Oncologist. 2012;17(11):1376-85. DOI: 10.1634/theoncologist.2011-0427 External link
4.
Goring SM, Gustafson P, Liu Y, Saab S, Cline SK, Platt RW. Disconnected by design: analytic approach in treatment networks having no common comparator. Res Synth Methods. 2016 Dec;7(4):420-432. DOI: 10.1002/jrsm.1204 External link
5.
Hainmuller J. Entropy balancing for causal effects: A multivariate reweighting method to produce balanced samples in observational studies. Political Analysis. 2012;20:25-56.
6.
Kalton G, Flores-Cervantes I. Weighting Methods. Journal of Official Statistics. 2003;19: 81-97.
7.
Kotapati S, Dequen P, Ouwens M. Overall survival (OS) in the management of pretreated patients with unresectable stage III/IV melanoma: A systematic literature review and meta-analysis. J Clin Oncol. 2011;29.
8.
Nixon R, Bergvall N, Tomic D, Sfikas N, Cutter G, Giovannoni G. No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosis. Adv Ther. 2014 Nov;31(11):1134-54. DOI: 10.1007/s12325-014-0167-z External link
9.
Signorovitch JE, Wu EQ, Yu AP, Gerrits CM, Kantor E, Bao Y, Gupta SR, Mulani PM. Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept. Pharmacoeconomics. 2010;28(10):935-45. DOI: 10.2165/11538370-000000000-00000 External link
10.
Stuart EA. Matching methods for causal inference: A review and a look forward. Stat Sci. 2010 Feb 1;25(1):1-21.
11.
Thom HH, Capkun G, Cerulli A, Nixon RM, Howard LS. Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertension. BMC Med Res Methodol. 2015 Apr 12;15:34. DOI: 10.1186/s12874-015-0007-0 External link